A Real-World Data Approach to Advance Research in Myasthenia Gravis
Studies of myasthenia gravis (MG) are essential for improving clinical care and informing drug development. However, the rarity of MG and wide geographic distribution of patients complicate site-based studies. In this study, we describe the development of a cohort of people living with MG in the US, UK and Canada. Real-world data collected from this cohort, including patient-reported data and insights from medical records, can be used by researchers and drug developers to accelerate new treatments for people affected by MG. This poster was presented at the MGFA International Conference in May, 2022.